# Ceres Nanosciences

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/ceres-nanosciences

- Industry: Biotechnology
- Headquarters: Manassas, US
- Website: www.ceresnano.com
- Total disclosed funding: $3M
- Latest round: Series A (Feb 2, 2017)
- Investors on record: 1

## About

Ceres Nanosciences, Inc. focuses on the development and commercialization of innovative Nanotrap particles that enhance the capture and concentration of low-abundance analytes, optimizing sample analysis across various biological applications.Ceres Nanosciences, Inc. specializes in advanced nanotechnology solutions, founded in 2008 and headquartered in Manassas, US. The company has pivoted to prioritize precision analytics and liquid biopsy technologies. The CEO is Ross Dunlap, who has experience in leading tech initiatives. In April 2021, the company raised USD 8.2 mn in a Grant from The National Institutes of Health, contributing to a total of USD 3.00 mn raised over two deals since inception.Ceres Nanosciences offers specialized products such as Nanotrap Microbiome Particles, the NEAT Liquid Biopsy Kit, and the Nanotrap Protein Enrichment Affinity Kit. These solutions are designed to work with various biological fluids, compatible with molecular assays, immunoassays, and mass spectrometry, serving clients in research, clinical laboratories, and industries like proteomics and food safety across North America, Europe, and Asia.Ceres Nanosciences generates revenue through direct B2B sales of its products, including the Nanotrap Microbiome Particles and NEAT Liquid Biopsy Kit. Revenue streams include one-time transactions and potential subscription models for ongoing supplies, supported by partnerships in relevant sectors to broaden market access and enhance distribution.Ceres Nanosciences plans to utilize the USD 8.2 mn Grant from April 2021 to develop and implement wastewater-based surveillance systems for COVID-19, leveraging their Nanotrap® particle technology to cater to underserved populations. The company is also targeting expansion into new geographic areas to enhance service delivery and increase its market presence.

## Funding rounds

- Series A, Feb 2, 2017, $3M — GreyBird Ventures

## Investors

- GreyBird Ventures (https://capitalatlas.ai/funds/greybird-ventures) — Series A
